Re Advisers »

Vaxcyte shares owned by Re Advisers

Quarter-by-quarter ownership of Vaxcyte (PCVX) shares owned by Re Advisers from 13F filings

Historical chart of Re Advisers investment in Vaxcyte

Tip: Access up to 7 years of quarterly data

All positions including Vaxcyte held by Re Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vaxcyte by Re Advisers

Quarter filed Position value Share count Share price at filing
2026-06-30 $2.0M 34k 58.13

More positions owned by Re Advisers

JPMorgan Chase & Co. (JPM)
Lam Research Corp Com New (LRCX)
Microsoft Corporation (MSFT)
Exxon Mobil Corporation (XOM)
Abbvie (ABBV)
Parker-Hannifin Corporation (PH)
Alphabet Cap Stk Cl C (GOOG)
Deere & Company (DE)
UnitedHealth (UNH)
Goldman Sachs (GS)
Amazon (AMZN)
Cisco Systems (CSCO)
Eaton Corp SHS (ETN)
Wal-Mart Stores (WMT)
Royalty Pharma Shs Class A (RPRX)

View all positions for Re Advisers

Top funds holding Vaxcyte

FMR
Jupiter Topco
Henderson Group
BlackRock
RA Capital Management
Wellington Management Company
Vanguard Portfolio Management
Vanguard Capital Management
State Street Corporation
Deep Track Capital
Geode Capital Management
Kynam Capital Management
Westfield Capital Management Company
Caligan Partners
Paradigm Biocapital Advisors

View all funds holding Vaxcyte